Riki Okita

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 21

Top Venues

Thoracic cancer

Scientific reports

Cancer immunology, immunotherapy : CII

Karolinska Institutet Cancer Center Karolinska

Hiroshima University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Karolinska Institutet Cancer Center Karolinska May 21 2009 - Mar 31 2012

Sweden

Post Doc :: Oncology-Pathology

Hiroshima University Apr 01 2008 - Apr 30 2009

Japan

Assistant Prof. :: Surgical Oncology

Hiroshima University Oct 01 2007 - Mar 31 2008

Japan

Assistant Prof. :: Clinical Oncology

Hiroshima University Apr 01 2005 - Sep 30 2007

Japan

Fellow :: Surgical Oncology

Kokuritsu Byoin Shikoku Gan Center Apr 01 2001 - Mar 31 2004

Japan

Resident :: Surgery

Education History

Hiroshima University

Japan

PHD :: Surgical Oncology

Publications

Riki Okita, Tomoya Senoo, Yuka Mimura-Kimura, Yusuke Mimura, Tomoyuki Murakami, Eiji Ikeda, Masanori Okada, Hidetoshi Inokawa, Keisuke Aoe
Characterizing soluble immune checkpoint molecules and TGF-β 1,2,3 in pleural effusion of malignant pleural mesothelioma. Scientific reports 14 (1) (2024)
Riki Okita, Tomoya Senoo, Yuka Mimura-Kimura, Yusuke Mimura, Tomoyuki Murakami, Eiji Ikeda, Masanori Okada, Hidetoshi Inokawa, Keisuke Aoe
Characterizing soluble immune checkpoint molecules and TGF-β 1,2,3 in pleural effusion of malignant pleural mesothelioma. Scientific reports 14 (1) (2024)
Riki Okita, Tomoya Senoo, Yuka Mimura-Kimura, Yusuke Mimura, Tomoyuki Murakami, Eiji Ikeda, Masanori Okada, Hidetoshi Inokawa, Keisuke Aoe
Characterizing soluble immune checkpoint molecules and TGF-β 1,2,3 in pleural effusion of malignant pleural mesothelioma. Scientific reports 14 (1) (2024)
Riki Okita, Tomoya Senoo, Yuka Mimura-Kimura, Yusuke Mimura, Tomoyuki Murakami, Eiji Ikeda, Masanori Okada, Hidetoshi Inokawa, Keisuke Aoe
Characterizing soluble immune checkpoint molecules and TGF-β 1,2,3 in pleural effusion of malignant pleural mesothelioma. Scientific reports 14 (1) (2024)
Riki Okita, Tomoya Senoo, Yuka Mimura-Kimura, Yusuke Mimura, Tomoyuki Murakami, Eiji Ikeda, Masanori Okada, Hidetoshi Inokawa, Keisuke Aoe
Characterizing soluble immune checkpoint molecules and TGF-β 1,2,3 in pleural effusion of malignant pleural mesothelioma. Scientific reports 14 (1) (2024)
Akira Tanaka, Riki Okita, Takushi Morishige, Masanori Okada, Hidetoshi Inokawa, Katsutoshi Hirazawa, Kaori Kameyama, Akihiko Ikeda, Eiji Ikeda
A case of primary lung adenocarcinoma mimicking metastatic papillary thyroid carcinoma. Thoracic cancer 15 (4) (2023)
Akira Tanaka, Riki Okita, Takushi Morishige, Masanori Okada, Hidetoshi Inokawa, Katsutoshi Hirazawa, Kaori Kameyama, Akihiko Ikeda, Eiji Ikeda
A case of primary lung adenocarcinoma mimicking metastatic papillary thyroid carcinoma. Thoracic cancer 15 (4) (2023)
Akira Tanaka, Riki Okita, Takushi Morishige, Masanori Okada, Hidetoshi Inokawa, Katsutoshi Hirazawa, Kaori Kameyama, Akihiko Ikeda, Eiji Ikeda
A case of primary lung adenocarcinoma mimicking metastatic papillary thyroid carcinoma. Thoracic cancer (2023)
Akira Tanaka, Riki Okita, Takushi Morishige, Masanori Okada, Hidetoshi Inokawa, Katsutoshi Hirazawa, Kaori Kameyama, Akihiko Ikeda, Eiji Ikeda
A case of primary lung adenocarcinoma mimicking metastatic papillary thyroid carcinoma. Thoracic cancer 15 (4) (2023)
Riki Okita, Nobutaka Kawamoto, Masanori Okada, Hidetoshi Inokawa, Naoki Yamamoto, Tomoyuki Murakami, Eiji Ikeda
Preoperative neutrophil-to-lymphocyte ratio correlates with PD-L1 expression in immune cells of patients with malignant pleural mesothelioma and predicts prognosis. Scientific reports 13 (1) (2023)
Akira Tanaka, Riki Okita, Takushi Morishige, Masanori Okada, Hidetoshi Inokawa, Katsutoshi Hirazawa, Kaori Kameyama, Akihiko Ikeda, Eiji Ikeda
A case of primary lung adenocarcinoma mimicking metastatic papillary thyroid carcinoma. Thoracic cancer 15 (4) (2023)
Riki Okita, Nobutaka Kawamoto, Masanori Okada, Hidetoshi Inokawa, Naoki Yamamoto, Tomoyuki Murakami, Eiji Ikeda
Preoperative neutrophil-to-lymphocyte ratio correlates with PD-L1 expression in immune cells of patients with malignant pleural mesothelioma and predicts prognosis. Scientific reports 13 (1) (2023)
Riki Okita, Yuka Mimura-Kimura, Nobutaka Kawamoto, Naoki Yamamoto, Masashi Umeda, Masanori Okada, Hidetoshi Inokawa, Yusuke Mimura, Tomoyuki Murakami, Masao Nakata, Kazunori Okabe
Effects of tumor-infiltrating CD8+ T cells, PD1/PD-L1 axis, and expression patterns of HLA class I on the prognosis of patients with malignant pleural mesothelioma who underwent extra-pleural pneumonectomy. Cancer immunology, immunotherapy : CII (2022)
Nobutaka Kawamoto, Riki Okita, Masataro Hayashi, Masanori Okada, Hidetoshi Inokawa
Tegafur-uracil-induced pericardial effusion during adjuvant chemotherapy for resected lung adenocarcinoma: A case report. Thoracic cancer 12 (5) (2021)
Riki Okita, Katsuhiko Shimizu, Yuji Nojima, Shinsuke Saisho, Masao Nakata
Tofacitinib overcomes an IFNγ-induced decrease in NK cell-mediated cytotoxicity via the regulation of immune-related molecules in LC-2/ad. Thoracic cancer 12 (6) (2021)
Nobutaka Kawamoto, Riki Okita, Masataro Hayashi, Masanori Okada, Kosuke Ito, Eiji Ikeda, Hidetoshi Inokawa
Suspected fibrin glue-induced acute eosinophilic pneumonia after pulmonary resection: A case report. Thoracic cancer 12 (14) (2021)
Nobutaka Kawamoto, Riki Okita, Hidetoshi Inokawa, Masataro Hayashi, Masashi Furukawa, Masanori Okada, Kazunori Okabe
Right upper lobectomy in lung cancer with double aortic arch: A case report. Thoracic cancer 11 (8) (2020)
Nobutaka Kawamoto, Masashi Furukawa, Riki Okita, Masanori Okada, Masataro Hayashi, Hidetoshi Inokawa, Kazunori Okabe, Keisuke Kawata
Contralateral pulmonary resection using selective bronchial blockade in postpneumonectomy patients. Thoracic cancer 11 (12) (2020)
Nobutaka Kawamoto, Riki Okita, Masataro Hayashi, Masashi Furukawa, Hidetoshi Inokawa, Kazunori Okabe
Rapid development and rupture of a pulmonary cyst in the early postoperative period after pulmonary resection: A case report. Thoracic cancer 11 (6) (2020)
Nobutaka Kawamoto, Masataro Hayashi, Riki Okita, Masanori Okada, Hidetoshi Inokawa, Taiga Kobayashi, Tadashi Maeda, Eiji Ikeda
Treatment strategy for primary lung cancer in a lung highly compressed by giant emphysematous bullae: A case report. Thoracic cancer 12 (2) (2020)
Riki Okita, Ai Maeda, Katsuhiko Shimizu, Yuji Nojima, Shinsuke Saisho, Masao Nakata
PD-L1 overexpression is partially regulated by EGFR/HER2 signaling and associated with poor prognosis in patients with non-small-cell lung cancer. Cancer immunology, immunotherapy : CII 66 (7) (2017)

Riki Okita.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Riki Okita